|
COQ6 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.329600E-01 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
1.636560E-01 |
| Normal-vs-Stage2 |
1.060310E-02 |
| Normal-vs-Stage3 |
3.204200E-02 |
| Normal-vs-Stage4 |
3.192300E-02 |
| Stage1-vs-Stage2 |
6.825100E-04 |
| Stage1-vs-Stage3 |
2.130800E-01 |
| Stage1-vs-Stage4 |
1.456980E-01 |
| Stage2-vs-Stage3 |
1.586060E-04 |
| Stage2-vs-Stage4 |
1.642760E-04 |
| Stage3-vs-Stage4 |
6.599000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
7.191700E-02 |
| Normal-vs-AfricanAmerican |
6.741400E-01 |
| Normal-vs-Asian |
8.851600E-01 |
| Caucasian-vs-AfricanAmerican |
6.095600E-01 |
| Caucasian-vs-Asian |
2.437600E-01 |
| AfricanAmerican-vs-Asian |
7.493200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
2.848600E-01 |
| Normal-vs-Female |
2.670600E-01 |
| Male-vs-Female |
8.656600E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.173600E-02 |
| Normal-vs-Age(41-60Yrs) |
3.110400E-01 |
| Normal-vs-Age(61-80Yrs) |
6.427800E-01 |
| Normal-vs-Age(81-100Yrs) |
1.174820E-01 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
2.875400E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
3.519600E-02 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.305800E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
1.866770E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
4.289200E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
2.623200E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
3.455600E-03 |
| Classical-VS-Follicular |
7.87360000531478E-08 |
| Classical-VS-Other |
8.250600E-01 |
| Classical-VS-Normal |
3.534000E-02 |
| Tall-VS-Follicular |
3.96869981322823E-10 |
| Tall-VS-Other |
7.516000E-02 |
| Tall-VS-Normal |
1.175210E-04 |
| Follicular-VS-Other |
1.380400E-02 |
| Follicular-VS-Normal |
1.439040E-03 |
| Other-VS-Normal |
5.365600E-01 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
9.857600E-01 |
| Normal-vs-N1 |
3.298100E-02 |
| N0-vs-N1 |
2.013900E-02 |
|
|
